Functional Assessment of Cancer Therapy - Bone Marrow Transplant
FACT-BMT
1 other identifier
observational
113
1 country
1
Brief Summary
Functional Assessment of Cancer Therapy - Bone Marrow Transplant
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 11, 2011
CompletedFirst Posted
Study publicly available on registry
December 13, 2011
CompletedDecember 13, 2011
December 1, 2011
December 11, 2011
December 11, 2011
Conditions
Keywords
Interventions
Eligibility Criteria
Lymphoma database
You may qualify if:
- Patients with newly diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma
You may not qualify if:
- Patients with diagnosis other than HD and NHL.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kfsh & Rc
Riyadh, Saudi Arabia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A Al-Zahrani, M.D.
KFSH & RC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2011
First Posted
December 13, 2011
Study Start
March 1, 2008
Last Updated
December 13, 2011
Record last verified: 2011-12